| Variables | Overall sample |
| % male | 233/303 (76.6%) |
| Mean age ± standard deviation | 36.4 ± 11.6 |
| Biochemical activity (n = 259) | 71 (27.4%) |
| Mean ALT | 43.3 ± 111 |
| Mean GGT | 43.4 ± 52.4 |
| HBeAg positive (n = 278) | 15 (5.4%) |
| HBV DNA <10 (n = 280) | 12.9% (n = 36) |
| HBV DNA ≥2000 IU/ml | 30.4% (n = 85) |
| Mean Log10 viral load B (IU/ml) | 7.4 ± 3.7 (0 - 20) |
| Anti-HDV antibodies positive | 14% = 53) |
| Mean Log10 viral load D | 10.8 ± 5.4 (0 - 10) |
| Histological activity |
|
| F ≥ 2 | 64 (43.8%) |
| A ≥ 2 | 21 (14.1%) |
| A or F ≥ 2 | 43.8% (n = 67) |
| METAVIR score |
|
| Fibrosis stage |
|
| 0 | 52 (34%) |
| 1 | 37 (24.2%) |
| 2 | 30 (19.6%) |
| 3 | 16 (10.5%) |
| 4 | 18 (11.8%) |
| Activity stage |
|
| 0 | 72.5% (108) |
| 1 | 13.4% (20) |
| 2 | 6.7% (10) |
| 3 | 7.4% (11) |